Yanzheng Gao
Zhengzhou, 471003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Histone acetyltransferase HAT1 drives malignant progression in lower-grade glioma: reshaping the immune microenvironment and molecular mechanisms.
Journal: Neuroscience
Published: August 19, 2025
Identification of tissue plasminogen activator (PLAT) as a potential target linking osteoarthritis and psoriasis: Integrated bioinformatics analysis and molecular dynamics simulation.
Journal: International journal of biological macromolecules
Published: August 13, 2025
Integrating single-cell transcriptomics, molecular docking, and dynamics simulations to characterize protein kinase X-linked mechanisms in osteosarcoma.
Journal: International journal of biological macromolecules
Published: July 11, 2025
Targeting FAP-positive chondrocytes in osteoarthritis: a novel lipid nanoparticle siRNA approach to mitigate cartilage degeneration.
Journal: Journal of nanobiotechnology
Published: August 13, 2024
High expression of ARPC1B promotes the proliferation and apoptosis of clear cell renal cell carcinoma cells, leading to a poor prognosis.
Journal: Molecular and cellular probes
Published: November 10, 2023
PSRC1 Regulated by DNA Methylation Is a Novel Target for LGG Immunotherapy.
Journal: Journal of molecular neuroscience : MN
Published: December 15, 2022
Aberrantly high DEPDC1B expression leads to poor prognosis in patients with lower-grade gliomas.
Journal: European review for medical and pharmacological sciences
Published: November 17, 2022
ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy.
Journal: The international journal of biochemistry & cell biology
Published: November 12, 2022
WD repeat domain 76 predicts poor prognosis in lower grade glioma and provides an original target for immunotherapy.
Journal: European journal of medical research
Published: October 15, 2022
Effects of ESCO2 or its methylation on the prognosis, clinical characteristics, immune microenvironment, and pathogenesis of low-grade glioma.
Journal: International immunopharmacology
Published: July 14, 2021
Last Updated: 09/26/2026